Found: 83
Select item for more details and to access through your institution.
Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
- Published in:
- Epilepsia (Series 4), 2008, v. 49, n. 9, p. 1555, doi. 10.1111/j.1528-1167.2008.01661.x
- By:
- Publication type:
- Article
Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis.
- Published in:
- Liver International, 2006, v. 26, n. 3, p. 285, doi. 10.1111/j.1478-3231.2005.01222.x
- By:
- Publication type:
- Article
Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1200897
- By:
- Publication type:
- Article
How to Manage Individualized Drug Therapy: Application of Pharmacogenetic Knowledge of Drug Metabolism and Transport.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2000, v. 38, n. 9, p. 869
- By:
- Publication type:
- Article
OpenVigil-free eyeballs on AERS pharmacovigilance data.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance
- Published in:
- Experimental Hematology & Oncology, 2020, v. 9, n. 1, p. N.PAG, doi. 10.1186/s40164-020-00183-1
- By:
- Publication type:
- Article
Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.696960
- By:
- Publication type:
- Article
Drug Interactions--Principles, Examples and Clinical Consequences.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate–glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans<sup>*</sup>
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 206, doi. 10.1016/j.clpt.2005.11.004
- By:
- Publication type:
- Article
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 3, p. 192, doi. 10.1016/j.clpt.2004.04.011
- By:
- Publication type:
- Article
CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 3, p. 213, doi. 10.1016/j.clpt.2003.10.004
- By:
- Publication type:
- Article
Correction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 1, p. 124, doi. 10.1016/S0009-9236(03)00233-9
- By:
- Publication type:
- Article
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 5, p. 584, doi. 10.1067/mcp.2002.129196
- By:
- Publication type:
- Article
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 5, p. 572, doi. 10.1067/mcp.2002.127739
- By:
- Publication type:
- Article
Effect of levothyroxine administration on intestinal P-glycoprotein expression: Consequences for drug disposition<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 256, doi. 10.1067/mcp.2002.126706
- By:
- Publication type:
- Article
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 326, doi. 10.1067/mcp.2002.127495
- By:
- Publication type:
- Article
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 3, p. 169, doi. 10.1067/mcp.2001.114164
- By:
- Publication type:
- Article
Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 4, p. 376, doi. 10.1016/S0009-9236(96)90104-6
- By:
- Publication type:
- Article
Interaction of CA repeat polymorphism of the endothelial nitric oxide synthase and hyperhomocysteinemia in acute coronary syndromes: evidence of gender-specific differences.
- Published in:
- Journal of Molecular Medicine, 2003, v. 81, n. 5, p. 305, doi. 10.1007/s00109-003-0433-z
- By:
- Publication type:
- Article
Molecular Genetics of Cancer Susceptibility.
- Published in:
- Pharmacology, 2000, v. 61, n. 3, p. 212
- By:
- Publication type:
- Article
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 11, p. 628, doi. 10.1159/000510258
- By:
- Publication type:
- Article
Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T<sub>3</sub>) supplementation.
- Published in:
- eLife, 2022, p. 1, doi. 10.7554/eLife.79405
- By:
- Publication type:
- Article
Pharmacovigilance‐based drug repurposing: The search for inverse signals via OpenVigil identifies putative drugs against viral respiratory infections.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 11, p. 4421, doi. 10.1111/bcp.14868
- By:
- Publication type:
- Article
Implementation and obstacles of pharmacogenetics in clinical practice: An international survey.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 9, p. 2076, doi. 10.1111/bcp.13999
- By:
- Publication type:
- Article
Opportunities and limitations: the value of pharmacogenetics in clinical practice.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 583, doi. 10.1111/bcp.12354
- By:
- Publication type:
- Article
Micro RNAs and their relevance to ABC transporters.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 587, doi. 10.1111/bcp.12251
- By:
- Publication type:
- Article
Pharmakogenetik.
- Published in:
- Medizinische Genetik, 2017, v. 29, n. 4, p. 389, doi. 10.1007/s11825-017-0146-2
- By:
- Publication type:
- Article
Pharmacogenomics of heart failure - focus on drug disposition and action
- Published in:
- Cardiovascular Research, 2004, v. 64, n. 1, p. 32, doi. 10.1016/j.cardiores.2004.06.003
- By:
- Publication type:
- Article
Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.92075
- By:
- Publication type:
- Article
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-43736-z
- By:
- Publication type:
- Article
CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 12, p. 1969, doi. 10.1093/carcin/23.12.1969
- By:
- Publication type:
- Article
Myeloperoxidase – 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients.
- Published in:
- Carcinogenesis, 2001, v. 22, n. 7, p. 1015, doi. 10.1093/carcin/22.7.1015
- By:
- Publication type:
- Article
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants.
- Published in:
- Carcinogenesis, 2001, v. 22, n. 3, p. 453, doi. 10.1093/carcin/22.3.453
- By:
- Publication type:
- Article
Modulation of benzo[a]pyrene diolepoxide–DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism.
- Published in:
- Carcinogenesis, 2000, v. 21, n. 1, p. 35, doi. 10.1093/carcin/21.1.35
- By:
- Publication type:
- Article
Retinoic acid–induced survival effects in SH‐SY5Y neuroblastoma cells.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 4, p. 5974, doi. 10.1002/jcb.27885
- By:
- Publication type:
- Article
Retinoic acid–induced survival effects in SH‐SY5Y neuroblastoma cells.
- Published in:
- Journal of Cellular Biochemistry, 2019, v. 120, n. 4, p. 5974, doi. 10.1002/jcb.27885
- By:
- Publication type:
- Article
Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.
- Published in:
- International Journal of Cancer, 2004, v. 110, n. 2, p. 266, doi. 10.1002/ijc.20114
- By:
- Publication type:
- Article
CYP1A1 T<sup>3801</sup> C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 5, p. 650, doi. 10.1002/ijc.10995
- By:
- Publication type:
- Article
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
- Published in:
- Nature Communications, 2014, v. 5, n. 9, p. 4757, doi. 10.1038/ncomms5757
- By:
- Publication type:
- Article
Drug Hypersensitivity.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The Nomenclature, Definition and Distinction of Types of Shock.
- Published in:
- Deutsches Ärzteblatt International, 2018, v. 115, n. 45, p. 757, doi. 10.3238/arztebl.2018.0757
- By:
- Publication type:
- Article
The Neurophysiology and Treatment of Motion Sickness.
- Published in:
- Deutsches Ärzteblatt International, 2018, v. 115, n. 41, p. 687, doi. 10.3238/arztebl.2018.0687
- By:
- Publication type:
- Article
Drug Hypersensitivity: Diagnosis, Genetics, and Prevention.
- Published in:
- Deutsches Ärzteblatt International, 2018, v. 115, n. 29/30, p. 501, doi. 10.3238/arztebl.2018.0501
- By:
- Publication type:
- Article
Limited Impact of 6-Mercaptopurine on Inflammation-Induced Chemokines Expression Profile in Primary Cultures of Enteric Nervous System.
- Published in:
- Neurochemical Research, 2021, v. 46, n. 7, p. 1781, doi. 10.1007/s11064-021-03324-y
- By:
- Publication type:
- Article
MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer’s Amyloid-β Peptides—Implications for the Mechanisms of Aβ Clearance at the Blood–Brain Barrier.
- Published in:
- Brain Pathology, 2007, v. 17, n. 4, p. 347, doi. 10.1111/j.1750-3639.2007.00075.x
- By:
- Publication type:
- Article
Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 204, doi. 10.1002/cpt.3270
- By:
- Publication type:
- Article
Clinical Pharmacology of Cannabinoid Therapeutics: Drug Interactions and Side Effects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 943, doi. 10.1002/cpt.3037
- By:
- Publication type:
- Article
Why is There Still Debate About Recommending DPYD‐Testing Before Fluoropyrimidine Treatment?
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 4, p. 733, doi. 10.1002/cpt.3016
- By:
- Publication type:
- Article
Progress and Challenges in Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 529, doi. 10.1002/cpt.2359
- By:
- Publication type:
- Article
Drug‐Drug‐Gene Interactions: A Call for Clinical Consideration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 3, p. 549, doi. 10.1002/cpt.2348
- By:
- Publication type:
- Article